"LABORATORIUM OBRAZOWANIA MOLEKULARNEGO I ROZWOJU TECHNOLOGII UNIWERSYTETU MEDYCZNEGO W BIAŁYMSTOKU" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID5423240688

KRS0000529548

Share capital500,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. ŻURAWIA 71A, 15-540 BIAŁYSTOK

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

"LABORATORIUM OBRAZOWANIA MOLEKULARNEGO I ROZWOJU TECHNOLOGII UNIWERSYTETU MEDYCZNEGO W BIAŁYMSTOKU" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. ŻURAWIA 71A, 15-540 BIAŁYSTOK

Show on map

NIP

5423240688

REGON

200894741

KRS

0000529548

Legal form

limited liability company

Register Address

UL. ŻURAWIA 71A, 15-540 BIAŁYSTOK

Date of registration in KRS

2014-10-31

Date of commencement of economic activity

2014-10-31

Act signature

BI.XII NS-REJ.KRS/9684/24/431/ADE

Pkd codes

86.90.E - Healthcare

70.10.Z - Head office activities

72.1 - Scientific research and development in natural and technical sciences

72.11 - Scientific research and development activities

74.90 - Other professional, scientific and technical activities, not elsewhere classified

77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright

78.30.Z - Employment activities

85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms

86.10.Z - Hospital activities

86.22.Z - Specialist medical practice

Payer VAT status

Active

Vat list bank account(s)

PL31 1240 5211 1111 0010 6002 6803

Company authorities

representation authorityMANAGEMENT

representation type

KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Assets	7,4	10,6	13,8	30,8
Gross profit (loss)	2,4	1,9	3,6	86,6
EBITDA	2,7	2,6	4,6	76,3
Net profit (loss)	2,2	1,8	2,9	65,7
Cash	6,5	2,2	6	170,4
Net income from sale	6,6	8,2	13,8	67,7
Liabilities and provisions for liabilities	0,2	1,6	1,9	20,4
Short time liabilities	0,2	1,6	1,9	20,4
Working assets	7	5,5	9,6	74,1
Equity capital	7,2	8,9	11,9	32,7
Operating profit (EBIT)	2,4	1,9	3,5	85,3
Depreciation	0,3	0,7	1,1	52,4
	%	%	%	p.p.
Profitability of capital	30,6	19,7	24,6	4,9
Equity capital to total assets	96,7	84,8	86	1,2
Gross profit margin	36,6	23,7	26,3	2,6
EBITDA Margin	40,3	31,5	33,1	1,6
	Days	Days	Days	Days
Short term commitment turnover cycle	13	71	51	-20